Advertisement
Advertisement

KYNB

K

Kyntra Bio, Inc. Common Stock

7.13
USD
Sponsored
+0.37
+5.47%
Jun 12, 16:00 UTC -4
Closed
exchange

After-Market

7.04

-0.09
-1.26%

KYNB Earnings Reports

Positive Surprise Ratio

KYNB beat 2 of 3 last estimates.

67%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.24M
/
-$3.33
Implied change from Q1 26 (Revenue/ EPS)
-66.71%
/
-11.44%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+77.13%

Kyntra Bio, Inc. Common Stock earnings per share and revenue

On May 11, 2026, KYNB reported earnings of -3.76 USD per share (EPS) for Q1 26, missing the estimate of -3.42 USD, resulting in a -9.87% surprise. Revenue reached 3.74 million, compared to an expected 1.34 million, with a 179.75% difference. The market reacted with a +6.25% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -3.33 USD, with revenue projected to reach 1.24 million USD, implying an decrease of -11.44% EPS, and decrease of -66.71% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, Kyntra Bio, Inc. Common Stock reported EPS of -$3.76, missing estimates by -9.87%, and revenue of $3.74M, 179.75% above expectations.
The stock price moved up 6.25%, changed from $6.80 before the earnings release to $7.22 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on -- analysts, Kyntra Bio, Inc. Common Stock is expected to report EPS of -$3.33 and revenue of $1.24M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement